Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Added another 10k shares today.........
>>>GO MGT!!!<<< WEEeee!
I'm sure the former Ceo's not a happy camper here.......Lol.
New Ceo has a 100 day plan in the works and cant wait for the future outcome, flying under the radar Imo.
$SEED Low float....."extremely volatile"......love it!
$SEED Naked Short Report:
Date Close High Low Volume Short Volume % of Vol Shorted
Jun 28 1.65 2.00 1.61 724,300 215,815 29.80%
Jun 27 1.96 1.98 1.71 948,100 350,329 36.95%
Jun 24 1.74 1.76 1.62 163,300 81,802 50.09%
Jun 23 1.72 1.77 1.67 74,500 15,023 20.17%
Jun 22 1.69 1.82 1.69 53,300 12,198 22.89%
Jun 21 1.71 1.79 1.67 66,500 10,526 15.83%
Jun 20 1.73 1.77 1.67 31,300 2,846 9.09%
Jun 17 1.71 1.87 1.70 224,500 48,366 21.54%
Jun 16 1.68 1.72 1.65 28,400 4,215 14.84%
Jun 15 1.72 1.74 1.66 54,300 1,805 3.32%
Jun 14 1.69 1.73 1.61 70,300 19,057 27.11%
Jun 13 1.64 1.71 1.61 258,800 58,830 22.73%
Jun 10 1.72 1.76 1.70 101,800 10,520 10.33%
Jun 09 1.75 1.81 1.71 128,600 44,773 34.82%
Jun 08 1.76 1.82 1.73 126,600 26,945 21.28%
Jun 07 1.77 1.82 1.73 253,700 63,274 24.94%
Jun 06 1.75 1.89 1.70 527,400 134,629 25.53%
Jun 03 1.75 1.83 1.72 270,300 44,098 16.31%
Jun 02 1.73 1.75 1.65 100,300 14,958 14.91%
Jun 01 1.66 1.72 1.65 107,800 13,884 12.88%
May 31 1.70 1.78 1.69 95,000 9,505 10.01%
http://nakedshortreport.com/index.php?index=SEED&market=NYX
$SEED Wow!!! what a day! Added a few this afternoon.... looking to double my position tomorrow. Former Ceo. Liang Yuan should be sold out by end of week. Gut tells me no news announcements until hes gone. Golden buying opportunity for me......Lol.
Dealmaking in agriculture is vibrant
The wave of agribusiness mergers and acquisitions is likely to continue rolling.
After several blockbuster deals that have been announced since December, analysts said the divestitures required to make those tie-ups possible should continue to fuel activity. Strategic buying and participation by private equity players are also expected to play a role.
Yet the prospective consolidation is not without opposition. As more M&A proposals surface across the industry, critics contend that additional activity will lessen competition throughout the sector, and drive up prices for farmers and consumers alike.
"If you look at how the seed and chemical market landscape looks in North America and Europe, it's very difficult to see all of these going ahead without some spinoffs being required," said Ben Isaacson, an analyst at Scotiabank in Toronto.
In the crop chemicals and seeds sectors, M&A activity has been driven largely by low commodity prices and a greater desire to achieve economies of scale, as well as efforts to lower costs and keep margins relatively stable, as farmer incomes remain under pressure.
On the fertilizer side (potash, phosphate and nitrogen), transactions have been driven by companies looking to expand retail distribution or add capacity to boost profits at a time where there's oversupply in fertilizers. It be can cheaper for an established company to buy existing assets, such as a potash mine, than to build them — and in so doing, the buyer can sometimes broaden its geographic presence and make an acquisition additive to earnings.
Activist investors have played a role in the consolidation frenzy by pushing for change and sometimes becoming supporters of deals, such as the proposed $130 billion merger of Dow Chemical and DuPont. Billionaire Nelson Peltz and his Trian Fund Management pushed for change at DuPont, which ultimately led to a deal with Dow Chemical.
"A Bayer/Monsanto combination helps to ensure the new company will remain a leader among a changing ag backdrop." -Brett Wong, PiperJaffray
Other big tie-ups in the works are state-owned China National Chemical (ChemChina), which has agreed to buy Swiss seeds and pesticide maker Syngenta for about $43 billion, as well as Bayer's new $62 billion unsolicited bid for Monsanto. The last formal response by Monsanto was in a release issued May 24, when it rejected the German chemical company's proposal. When contacted last week about the offer, a Monsanto spokesperson said the company does "not intend to comment further regarding the status of any discussions."
"In our view, a Bayer/Monsanto combination helps to ensure the new company will remain a leader among a changing [agribusiness] backdrop with a more formidable competitor in Dow/DuPont and likely market disruption from the potential Syngenta/ChemChina combination," Piper Jaffray analyst Brett Wong said in a research note this month.
Wong said Bayer would likely need to shed some assets to avoid regulatory issues getting in the way of a potential closing.
"For antitrust purposes, we expect that Bayer will have to divest seed crossover, which would be primarily cotton, canola and some vegetables," he said. "Assuming that BASF is the stand-alone ... [agribusiness] major at the end of this consolidation wave, we believe BASF (a chemical producer based in Germany) would potentially be a leading strategic buyer of the divested seed assets given its historical intent to purchase a seed business."
France's seed and cereal products company Groupe Limagrain might want "various seed assets" from Bayer, Wong added. And Australia's Nufarm or India's Mahyco may want in on the action too, he said.
If Bayer's herbicides were divested to push through the transaction, there would be buyer interest for those assets as well, according to the Piper analyst. He said if a strategic buyer were to pass on Bayer assets that might be shed, there's a chance private equity (including agribusiness-focused funds) might pursue such a transaction.
Meanwhile, another agriculture-related deal could go down in the next few weeks — fertilizer company Mosaic and Brazil's Vale. Reuters has reported the two are in talks for Mosaic to buy Vale's fertilizer unit, valued at about $3 billion. Based on the report, that would leave Vale as the largest shareholder in Mosaic, a Minnesota-based company formed in 2004 by the merger of IMC Global with Cargill's fertilizer business. Mosaic and Vale declined comment.
Some lawmakers and critics of the consolidation believe the concentration of agribusiness ownership into fewer hands is bad news for farmers' wallets and ultimately, consumers.
"Our concern as competition advocates is that this is not good for farmers at all," said Diana Moss, president of the American Antitrust Institute, a nonprofit group that is protesting the Dow Chemical and DuPont deal. "We know farmers have already paid higher prices for (seed) biotechnology … and are getting squeezed on the other end as well in terms of the prices that they receive for their crops."
The Dow and DuPont merger would result in a newly created company, DowDuPont, with significant agricultural and chemical operations around the globe. It would eventually create three spinoffs, including an independent agribusiness unit. With about $20 billion in revenue, that new agribusiness spinoff would leapfrog Monsanto, the St. Louis-based seed and tech powerhouse with $15 billion in revenue in its latest fiscal year.
Sen. Charles Grassley, R-Iowa, who chairs the Senate Committee on the Judiciary, this month wrote a letter to the U.S. Department of Justice's Antitrust Division expressing concerns the Dow and DuPont deal "will decrease competition in an agricultural sector that has already been subject to a number of waves of consolidation in recent years."
"I have heard concerns that the proposed merger will alter agricultural input markets for seeds and chemicals," Grassley wrote in the letter dated June 14.
"I have heard concerns that the merger will vertically integrate traits, seeds and chemicals, which will make it more difficult for smaller biotechnology companies, independent producers and independent crop input companies to compete," he continued. "I also have heard concerns that the merger will reduce cultivation, chemical and seed choices for farmers, as well as raise prices for them, which ultimately will impact consumers and the food system."
A spokesperson for Dow Chemical defended the proposed deal in a prepared statement issued to CNBC.
"We are cooperating with regulatory authorities as they review the proposed merger transaction, which we believe is pro-competitive and good for farmers and consumers. We anticipate that the regulatory review will be a thorough process," the statement said.
Midland, Michigan-based Dow Chemical says the proposed deal is likely to close in the second half of 2016, subject to customary regulatory clearances and stockholder approval. Dow Chemical expects the planned spinoff of three independent, publicly traded companies to happen "as soon as practical, but not to exceed 18 to 24 months after the transaction closing."
Stockholder meetings to vote on the proposed Dow Chemical/DuPont merger are scheduled for July 20.
Grassley and others have likewise expressed concern that consolidation within the agricultural biotechnology sector could ultimately curtail research and development activities and industry innovation.
"ChemChina's existing crop protection business is relatively small and there is very limited overlap with Syngenta," a spokesperson for Syngenta said in a written statement. "Following the transaction Syngenta will remain Syngenta, with a broad portfolio and geographic presence, and with a long-term commitment to R&D investment across technology platforms and across crops."
"The transaction therefore ensures continued choice for growers at a time when considerable consolidation is taking place in the agricultural industry."
Syngenta expects the deal with ChemChina, which was announced in February, to close by the end of the year.
http://www.cnbc.com/2016/06/27/dealmaking-in-agriculture-is-vibrant-causing-some-to-worry.html?__source=yahoo%7Cfinance%7Cheadline%7Cheadline%7Cstory&par=yahoo&doc=103741755
$MGT Bullish 34k long......
$SEED Green today in a sea of red......
Wish I could be positive about this company, but this is the best they can offer after 4 plus years.........Sysmex deal wouldn't have fallen apart if they thought it was a viable product......JMHO GLTA
I see this latest PR as an attempt to save what ever credibility and finances this company my still have......not seeing much for shareholder benefits here other then the fact the company can survive another year without dilution of shares.......managements been living high on the hog past 12 months Imo.
Departure of Directors or Certain Officers
On June 14, 2016, Mr Robert Galvin was removed as Principal Financial Officer, Treasurer and director of the Company for cause, based on his not explaining certain expenses charged to the Company's subsidiary Bio-Alternative Medical Devices Limited ("Bio") over a two year period.
The registrant has conducted a preliminary investigation into Mr Galvin causing Bio to pay a rental in 2014 and 2015 ostensibly for Bio's use of Mr Galvin's ARM Partnership ("ARM") offices located at 14, South Molton Street, London ("Rental"). The Company believes that (a) the Rental was not required by Bio as it had and has far more appropriate offices at its operational headquarters; (b) Mr Galvin is unable to name any meetings that took place that would have required the Rental; (c) the ARM offices were not wheelchair accessible to one of Bio's directors; (d) the Rental appears to have been paid from two unsecured loans sought by Mr Galvin on behalf of Bio and loaned down from the Company for business purposes such as equipment, contracted design work and to aid the closing of commercial contracts; and (e) Mr Galvin was already contracted by Bio to work from the ARM offices. The Company seeks to discover if the Rental was a means by which Mr Galvin was supplementing his income as paid through ARM, which was not intended in his employment arrangement.
Mr Galvin also caused Bio to change his day rate consultancy contract with Bio to a monthly salary regardless of days worked, which is believed in breach of a Subscription and Shareholders' Agreement entered into by the Company, Mr Galvin and others, and otherwise not economically justified on the basis of the workload.
Mr Galvin's and ARM's position taken in respect of the investigations and questions raised by the foregoing is that the board of directors of Bio agreed to the actions and payments were approved from time to time. The Company disagrees, and does not believe responsibility can simply be shifted to other directors who contend that they were deliberately misled, or that responsibility is mitigated by time passing and repeated payments.
Appointment of Certain Officers
On June 14, 2016 our President and director, Mr David Miller, who is responsible for the management of our periodic filings, was appointed as Principal Financial Officer and Treasurer for the time being, supported by our UK and US accountants.
https://biz.yahoo.com/e/160620/biad8-k.html
Changing Of The Guard PRICE TARGET $15
This past April, Origin Agritech (Nasdaq: SEED $1.70) woke up the investment world by licensing its technology to agricultural powerhouse Dupont/Pioneer. Two weeks later, as an encore, Origin Agritech made an even bigger unexpected move by hiring one of Dupont’s top executives, Dr. William S. Niebur to become President and CEO. Then in early May, the company hired another Dupont veteran, Shashank Aurora to become CFO. Unquestionably, these three developments are game changing moves for this overlooked Chinese seed company with an agritech program that mimics Syngenta, Monsanto and Dupont in the multi $100 billion agricultural business. After some deep research we believe Origin Agritech is poised to refresh its management team, open up its biotech pipeline and most importantly, improve communications with both the agricultural industry and Wall Street. We view this as the rebirth or Re-IPO of SEED and predict the changing of the guard could see shares hit $10 by year end and $15 in 12-18 months, a price it last hit in 2009.
Origin Agritech is a technology-focused crop seed provider that’s positioning itself to be a global participant in the biotechnology and agricultural seeds industry.
In 2014, Origin Agritech was approached by Hunan Xindaxin Co. (a Chinese state-backed firm) with an unsolicited offer of $2.50 per share for the company. The company declined the offer in Chinese fashion – very slowly! However, when the Chinese commit to something then they do it – very fast. After being rebuffed by Origin Agritech, the Chinese Government backed ChemChina with its $43 billion acquisition of Swiss based firm Syngenta. We believe that the Chinese Government and Origin Agritech are both approaching the GMO/Hybrid seed adoption at similar speeds, but through different methods. The Chinese Government through acquisition and Origin Agritech by acquiring top industry talent. With shared goals of jumpstarting GMO/hybrid seed activity in China and it is certain to bring a much higher stock price than $2.50
The Re IPO Non Deal Roadshow
Once the new CEO of Origin Agritech, Dr. Niebur speaks to Wall Street, the top hedge funds are going to want to own 5-10% of the shares. The new management team will possess the pedigree of a Dupont ag team, but in a micro cap company affording Origin Agritech the flexibility to become a large cap agricultural play in 2-4 years. Origin Agritech’s technology has been validated thru Dupont’s licensing the technology and the hiring of Dupont executives. No one knows the specifics of DuPont licensing its technology, but a non deal roadshow could potentially open up some of the details of the deal which could further propel the shares. Per the Chairman’s comments in the last conference call in January that there are 1-2 active deals still in the pipeline. The company has spent the last 10 years developing a deep biotech pipeline through its own cash-flow and the government’s backing thru key universities (CAAS). The landing of a top notch CEO and CFO brings credibility and transparency to its financials, technology and leveraging the international expansion potential. These are all the ingredients to spur excitement and price action into the shares in both the short, medium and long term. This opportunity is just too good to be true and we’re marveling at how the share price ($1.70 – $1.80) has maintained its current levels at or near the 50 day moving average for so long.
The Masking of the Progress
Last week, Liang Yuan who was Origin Agritech’s CEO from 2012 to 2013 filed that he sold 531k shares of stock between $1.68 – $2.49 from late April to late May. His selling occurred as the company announced a westerner as its CEO. Strangely, it didn’t occur when the company announced its licensing deal with Dupont on April 5, 2016 when shares spiked to $2.48 on 5 million shares. This pattern shows (with speculation) that he’s not in the know and could be upset with a westerner taking the helm as the new CEO. A degree of ignorance could be at hand. The selling doesn’t make sense unless he’s in need of immediate cash( rumor has him running an online gaming business which usually requires cashflow), or if he had a falling out with the Chairman. In any event, his selling is masking the incredible strides made by Origin Agritech and probably the main reason shares have been capped at the 50 day moving average.
New CEO & CFO:
Shares of SEED should have traded much higher with the successful landing of Dr. William Niebur, a 33 year in-house journeyman at Dupont/Pioneer. During his 33 years he went way beyond the corn fields of Iowa on his path to becoming a corporate insider at Dupont/Pioneer. He ran divisions at Dupont which spanned three continents and was head of R&D in the agricultural planting division and ended his career running the Far East/China group these last 5 years. It’s of our opinion, he was instrumental in the behind the scenes work with Origin Agritech and had Dupont/Pioneer’s workforce working side by side Origin Agritech’s for the better part of 5 years before the two companies went public on April 5, 2016 with a licensing deal two weeks prior to Dr. Niebur joining Origin Agritech. In only 2 short weeks, Niebur placed another Dupont executive, Shashank Aurora, to become CFO of Origin Agritech. These two hires tells us Origin Agritech has been hard at work to turn the reigns over to more high profile westerners with more transparency and validation as China prepares going pro GMO.
The one obvious sign that has drawn our appeal is the fact that these two professionals accumulated 55 years at blue chip Dupont. This undoubtedly speaks to their Character and professional acumen, which could be described as being purposeful, thoughtful, diligent and careful in evaluating their move to Origin. The transition to a micro cap in China is against the grain on the surface, so there must be much greater opportunity here than meets the eye. Otherwise these two blue chip career oriented executives would never consider the move. This could be the first thing that comes to the surface when they present at their first non deal road show in the coming months.
Below, are two videos of William Niebur speaking on Dupont’s China strategies when he was appointed VP of Far east China.
https://eximiuscapitalgroup.wordpress.com/2016/06/22/first-blog-post/
I suppose anything from management at this point would be a plus.....announcement of a deal would send this into orbit....
I have none at this point....hoping To hear from the new CEO soon with huge expectations for $SEED.... possible merger in the future?
$SEED shares thinly traded, hard to accumulate..... was able to pick up a another 10k shares today......
That sounds better Thanks
Perhaps miracles do happen.....
Not looking good for us two old timers.......Lol.
That would definitely be explosive to this mega low floater $SEED
Cant believe the share structure on this, although I do see some major debt.......
Doubled my position In $GSAT today.....I see a 318,000 buy @ $2.59 A/H
$BIAD's Been a 4 year disappointment to say the least......
In with 20k..........$CJES
$SEED has a 15.5 mil. float...... could go up in like a rocket!
Took a start position in $SEED today.......
I agree! $BIAD They'll reach an agreement with a new haematology company for the licensing of COAG, Never dreamed our deal with Sysmex Corporation would fail to consummate.
Holding a bag full on this one........Lol.
Back in MGT @ $3.28 20k shares......GLTA
$GSAT Getting jiggy!!!
added @ $2.64.....
Needs to fill the gap $2.65 I'll add again.....
added another 5k shares GSAT @ $2.80......
Out @ $1.11 will re inter at a lower PPS
added another 5k shares.......
Thanks! I seen that as well, bought in as fast as I could after reading it......Lol.
Sounds like a plan...... I Like the possibility's here
$SYMX also took start position $1.10
$GSAT Got a start position @ $2.75......
I would be chasing then.....Lol.
$25,000 that's awesome!!!! Keep an eye on support and resistance levels,and don't forget to take profit......
MGT is amazing!!!! going much higher in days to come